March 2011

Featuring:
Jason Ferrone of Isis Pharmaceuticals and Barbara Rudolph of Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Topic:
Issues raised by the Myriad Genetics Decision and appeal to the CAFC